期刊文献+

基质金属蛋白酶-1在非小细胞肺癌组织中的表达及临床意义

The expression of MMP-1 in patients with primary non-small cell lung cancer (NSCLC) and its clinical significance.
暂未订购
导出
摘要 的研究基质金属蛋白酶-1(MMP-1)在非小细胞肺癌组织中的表达及临床意义。方法应用免疫组织化学方法和Westernblotting检测70例非小细胞肺癌组织中MMP-1蛋白的表达,并进行图像分析测定电泳条带的吸光度A值。结果70例非小细胞肺癌和30例正常肺组织中MMP-1表达阳性的例数分别为33例(47.1%)和7例(23.3%),差别具有显著意义。Ⅲ期肺癌的平均吸光度A值明显高于Ⅰ、Ⅱ期。有淋巴结转移癌的平均吸光度A值明显高于无淋巴结转移的病例,差异具有显著性意义(P<0.05)。MMP-1在肺腺癌和鳞癌中的表达无显著性差异(P>0.05)。结论MMP-1在非小细胞肺癌组织中的表达增多,与非小细胞肺癌分期、淋巴结转移有关。 Objective To explore the expression level of MMP-1 in patients with primary non-small cell lung cancer (NSCLC). Methods The expression of MMP-1 protein was detected in 70 NSCLC tissues by immunochemistry and Western blotting followed by image analysis in order to detect the A value of expression. Results The positive rate of MMP-1 expression in NSCLC tissues was 47.1% (33/70), higher than that in normal lung tissue. There was no significant difference in MMP-1 expression between NSCLC tissues of squamous cell carcinoma and adenocarcinoma(P>0.05). The A value of MMP-1 expression in NSCLC tissues of Ⅲ stage was significantly higher than that in NSCLC tissues ofⅠ,Ⅱstages ( P<0.05). The A value of MMP-1 expression in NSCLC tissues of N1,2,3 groups was significantly higher than that in NSCLC tissues of N0 group ( P<0.05). MMP-1 expression was related to lymph node metastasis (P<0.05) and TNM stages of lung cancer (P<0.05), but not to the histological classification. Conclusion MMP-1 protein expression may be associated with the invasion and progression of NSCLC.
出处 《现代肿瘤医学》 CAS 2005年第3期329-331,共3页 Journal of Modern Oncology
关键词 MMP-1 非小细胞肺癌 免疫组织化学 WESTERN BLOTTING MMP-1 NSCLC immunochemistry Western blotting
  • 相关文献

参考文献6

  • 1Brummer O, Bohmer G, Hollwitz B,et al. MMP-1 and MMP-2 in the cervix uteri in different steps of malignant transformation--an immunohistochemical study[J]. Gynecol Oncol,2002,84(2):222~227.
  • 2Bendardaf R, Lamlum H, Vihinen P, et al. Low collagenase-1 (MMP-1) and MT1-MMP expression levels are favourable survival markers in advanced colorectal carcinoma[J]. Oncology,2003,65(4):337~346.
  • 3Schutz A, Schneidenbach D, Aust G, et al. Differential expression and activity status of MMP-1, MMP-2 and MMP-9 in tumor and stromal cells of squamous cell carcinomas of the lung[J]. Tumour Biol, 2002 ,23(3): 179~184.
  • 4欧阳取长,胡成平,梁清华,石林阶,吴鄂生,杨红忠,潘频华.应用cDNA微阵列技术研究MMP1,TIMP1基因在肺癌中的表达[J].湖南医科大学学报,2003,28(3):227-228. 被引量:1
  • 5Seiki M. Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion[J]. Cancer Lett, 2003,194(1): 1~11.
  • 6Sugioka Y, Watanabe T, Inagaki Y, et al. C-Jun NH2-terminal kinase pathway is involved in constitutive matrix metalloproteinase-1 expression in a hepatocellular carcinoma-derived cell line[J]. Int J Cancer,2004,109(6): 867~874.

二级参考文献8

  • 1FongKⅢ Kida Y Zimmerman PV.TIMP1 and adverse prognosis in non-small cell lung cancer[J].Clin Cancer Res,1996,2:1369-1372.
  • 2Schutz A, Schneidenbach D, Aust G, et al. Differential expression and activity status of MMP1 ,MMP2 and MMP9 in tumor and stroreal cells of squmas cell carcinomas of the lung [ J ]. Tumor Biol,2002,23 : 179 -184.
  • 3Zhu Y,Spitz MR,Lei L,et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility[ J ]. Cancer Res,2001,61:7825-7829.
  • 4Fong K III, Kida Y, Zimmerman PV. TIMP1 and adverse prognosis in non-small cell lung cancer [ J]. Clin Cancer Res, 1996,2:1369-1372.
  • 5Lein III, Nowak I, Jung K, et al. Metslloproteinases ( MMP1,MMP3) and their inhibitors(TIMP) in blood plasma of patients with prostate carcinoma[ J]. Urologea, 1998,37:337-338.
  • 6Pellegrini P, Contasta I, Berghella A III. Simultaneous measurment of soluble carcinoembrgonic antigen and the tissue inhibitor of metalloproteinase TIMP1 serum levels for use as markers of preinvasive to invasive colorectal cancer[ J ]. Immunol Immunother,2000,49:388-394.
  • 7Ylisimio S, Hoyhtyo M, Turpeenniemi-hujanen T. Serum matrix metalloproteinases-2,-9 and tissue inhibitors of metalloproteinas-es-1 ,-2 in lung eaneer-TIMP-1 as a prognostic marker [ J ]. Anticancer Res ,2000,20 : 1311-1316.
  • 8Heighway J, Knapp T, Boyce L, et al. Expression profiling of primary non-small cell lung cancer for target identification[ J]. Oncogene ,2002,21:7749-7763.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部